Quantamental Technologies LLC Argenx Se Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $461,260 - $531,888	-1,344 Reduced 37.3%	2,259 $798,000
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $971,296 - $1.37 Million	3,603 New	3,603 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $95,931 - $147,789	-900 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$113.31 - $150.51 $101,979 - $135,459	900 New	900 $103,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.